The vestibular disorders, which generally manifest themselves as nausea, vomiting, and dizziness or vertigo, have troubled many people. Increasing evidence suggests that certain vestibular disorders are hereditary, and gene variants contribute to the onset and susceptibility of these disorders. This review summarizes the latest research progress, especially the molecular and genetic aspects of several common vestibular disorders, including Meniere’s disease, vestibular migraine, benign paroxysmal positional vertigo, and motion sickness, with the aim of encouraging more fundamental research and enhancing our understanding of the molecular and genetic mechanisms underlying vestibular disorders.
DuncanJSFritzschB. Transforming the vestibular system one molecule at a time: the molecular and developmental basis of vertebrate auditory evolution. Adv Exp Med Biol2012; 739: 173–186.
2.
MaudouxAVitrySEl-AmraouiA. Vestibular deficits in deafness: clinical presentation, animal modeling, and treatment solutions. Front Neurol2022; 13: 816534.
3.
OhAK. Genetics of vestibulopathy and migraine. Curr Opin Otolaryngol Head Neck Surg2013; 21: 469–472.
FrejoLLopez-EscamezJA. Recent advances in understanding molecular bases of Ménière's disease. Fac Rev2023; 12: 11.
8.
SenofskyNFaberJBozovicD. Vestibular drop attacks and meniere's disease as results of otolithic membrane Damage-A numerical model. J Assoc Res Otolaryngol2023; 24: 107–115.
9.
FrejoLGallego-MartinezARequenaT, et al.Proinflammatory cytokines and response to molds in mononuclear cells of patients with meniere disease. Sci Rep2018; 8: 5974.
10.
ZhangNLyuYGuoJ, et al.Bidirectional transport of IgE by CD23 in the inner ear of patients with meniere's disease. J Immunol2022; 208: 827–838.
11.
ZouJZhaoZZhangG, et al.MEFV, IRF8, ADA, PEPD, and NBAS gene variants and elevated serum cytokines in a patient with unilateral sporadic Meniere's disease and vascular congestion over the endolymphatic sac. J Otolaryngol2022; 17: 175–181.
12.
PathakSVambutasA. NaCl exposure results in increased expression and processing of IL-1β in Meniere's disease patients. Sci Rep2022; 12: 4957.
13.
BrownMR. The factor of heredity in labyrinthine deafness and paroxysmal vertigo; Ménière's syndrome. Ann Otol Rhinol Laryngol1949; 58: 665–670.
14.
Parra-PerezAMLopez-EscamezJA. Types of inheritance and genes associated with familial meniere disease. J Assoc Res Otolaryngol2023; 24(3): 269–279.
15.
FrykholmCKlarJTomanovicT, et al.Stereocilin gene variants associated with episodic vertigo: expansion of the DFNB16 phenotype. Eur J Hum Genet2018; 26: 1871–1874.
16.
Roman-NaranjoPGallego-MartinezASoto-VarelaA, et al.Burden of rare variants in the OTOG gene in familial meniere's disease. Ear Hear2020; 41: 1598–1605.
17.
Roman-NaranjoPParra-PerezAMEscalera-BalseraA, et al.Defective α-tectorin may involve tectorial membrane in familial Meniere disease. Clin Transl Med2022; 12: e829.
18.
Roman-NaranjoPMoleonMDCAranI, et al.Rare coding variants involving MYO7A and other genes encoding stereocilia link proteins in familial meniere disease. Hear Res2021; 409: 108329.
19.
FurutaTTeranishiMUchidaY, et al.Association of interleukin-1 gene polymorphisms with sudden sensorineural hearing loss and Ménière's disease. Int J Immunogenet2011; 38: 249–254.
20.
SkarpSKanervoLKotimäkiJ, et al.Whole-exome sequencing suggests multiallelic inheritance for childhood-onset Ménière's disease. Ann Hum Genet2019; 83: 389–396.
21.
OhEHShinJHKimHS, et al.Rare variants of putative candidate genes associated with sporadic meniere's disease in East Asian population. Front Neurol2019; 10: 1424.
22.
RequenaTGazquezIMorenoA, et al.Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease. Immunogenetics2013; 65: 345–355.
23.
YazdaniNKhorsandi AshtianiMTZarandyMM, et al.Association between MIF gene variation and Meniere's disease. Int J Immunogenet2013; 40: 488–491.
24.
Lopes KdeCSartoratoELda Silva-CostaSM, et al.Ménière's disease: molecular analysis of aquaporins 2, 3 and potassium channel KCNE1 genes in Brazilian patients. Otol Neurotol2016; 37: 1117–1121.
25.
CandreiaCSchmuzigerNGürtlerN. Molecular analysis of aquaporin genes 1 to 4 in patients with Menière's disease. Cell Physiol Biochem2010; 26: 787–792.
26.
DaiQWangDZhengH. The polymorphic analysis of the human potassium channel KCNE gene family in meniere's Disease-A preliminary study. J Int Adv Otol2019; 15: 130–134.
27.
DoiKSatoTKuramasuT, et al.Ménière's disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J Otorhinolaryngol Relat Spec2005; 67: 289–293.
28.
HietikkoEKotimäkiJOkuloffA, et al.A replication study on proposed candidate genes in Ménière's disease, and a review of the current status of genetic studies. Int J Audiol2012; 51: 841–845.
29.
TeggiRZagatoLDelli CarpiniS, et al.Genetics of ion homeostasis in Ménière's disease. Eur Arch Otorhinolaryngol2017; 274: 757–763.
30.
NairTSKommareddiPKGalanoMM, et al.SLC44A2 single nucleotide polymorphisms, isoforms, and expression: association with severity of Meniere's disease?Genomics2016; 108: 201–208.
31.
SkarpSKorvalaJKotimäkiJ, et al.New genetic variants in CYP2B6 and SLC6A support the role of oxidative stress in familial ménière's disease. Genes2022; 13: 998.
32.
Lopez-EscamezJASaenz-LopezPAcostaL, et al.Association of a functional polymorphism of PTPN22 encoding a lymphoid protein phosphatase in bilateral Meniere's disease. Laryngoscope2010; 120: 103–107.
33.
Martín-SierraCRequenaTFrejoL, et al.A novel missense variant in PRKCB segregates low-frequency hearing loss in an autosomal dominant family with Meniere's disease. Hum Mol Genet2016; 25: 3407–3415.
34.
QinDZhangHWangJ, et al.Histamine H4 receptor gene polymorphisms: a potential contributor to Meniere disease. BMC Med Genom2019; 12: 71.
35.
KawaguchiSHagiwaraASuzukiM. Polymorphic analysis of the heat-shock protein 70 gene (HSPA1A) in Ménière's disease. Acta Otolaryngol2008; 128: 1173–1177.
36.
RequenaTCabreraSMartín-SierraC, et al.Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere's disease. Hum Mol Genet2015; 24: 1119–1126.
37.
Martín-SierraCGallego-MartinezARequenaT, et al.Variable expressivity and genetic heterogeneity involving DPT and SEMA3D genes in autosomal dominant familial Meniere's disease. Eur J Hum Genet2017; 25: 200–207.
38.
FransenEVerstrekenMVerhagenWI, et al.High prevalence of symptoms of Menière's disease in three families with a mutation in the COCH gene. Hum Mol Genet1999; 8: 1425–1429.
39.
MehrjooZKahriziKMohseniM, et al.Limbic system associated membrane protein mutation in an Iranian family diagnosed with Ménière's disease. Arch Iran Med2020; 23: 319–325.
40.
GaoYWangDWangH, et al.Cinical and genetic characteristics of familial Meniere's disease: three families report. Zhonghua er bi yan hou tou jing wai ke za zhi2015; 50: 915–924.
41.
Gallego-MartinezARequenaTRoman-NaranjoP, et al.Excess of rare missense variants in hearing loss genes in sporadic meniere disease. Front Genet2019; 10: 76.
FormeisterEJRizkHGKohnMA, et al.The epidemiology of vestibular Migraine: a population-Based survey study. Otol Neurotol2018; 39: 1037–1044.
44.
NeuhauserHKRadtkeAvon BrevernM, et al.Migrainous vertigo: prevalence and impact on quality of life. Neurology2006; 67: 1028–1033.
45.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. 3rd ed.Cephalalgia, 2018, 38, pp. 1–211.
Cantillo-MartinezMLorente-PieraJManrique-HuarteR, et al.Insights into vestibular migraine: diagnostic challenges, differential spectrum and therapeutic Horizons. J Clin Med2025; 14.
48.
Espinosa-SanchezJMLopez-EscamezJA. New insights into pathophysiology of vestibular migraine. Front Neurol2015; 6: 12.
49.
AlabbadSFigueredoNYuanH, et al.Developments in targeting calcitonin gene-related peptide. Expert Rev Neurother2024; 24: 477–485.
50.
FrosoliniALovatoA. Monoclonal antibodies targeting CGRP to treat vestibular migraine: a rapid systematic review and meta-analysis. Indian J Otolaryngol Head Neck Surg2024; 76: 3737–3744.
51.
HoskinJLFifeTD. New Anti-CGRP medications in the treatment of vestibular migraine. Front Neurol2021; 12(2021): 799002.
52.
InuiTKimuraFMoriyamaK, et al.Evaluation of vestibular functions in a case of vestibular migraine with successful treatment with erenumab. Ear Nose Throat J2025; 104: 359s–363s.
53.
KougaTMiwaTSunamiK, et al.Effectiveness of anti-calcitonin gene-related peptide medication in vestibular migraine: a retrospective cohort study in an Asian population. CNS Drugs2024; 38: 637–648.
54.
LovatoADiscoCFrosoliniA, et al.Monoclonal antibodies targeting CGRP: a novel treatment in vestibular migraine. Medicina2023; 59: 1560.
55.
RussoCVSaccàFBracaS, et al.Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: a prospective observational cohort study. Cephalalgia2023; 43: 3331024231161809.
56.
TianRZhangYPanQ, et al.Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model. J Headache Pain2022; 23: 35.
57.
BahmadFJr.DePalmaSRMerchantSN, et al.Locus for familial migrainous vertigo disease maps to chromosome 5q35. Ann Otol Rhinol Laryngol2009; 118: 670–676.
58.
LeeHSiningerLJenJC, et al.Association of progesterone receptor with migraine-associated vertigo. Neurogenetics2007; 8: 195–200.
59.
FrejoLGieglingITeggiR, et al.Genetics of vestibular disorders: pathophysiological insights. J Neurol2016; 263(Suppl 1): S45–S53.
60.
OhEHShinJHChoJW, et al.TRPM7 as a candidate gene for vestibular migraine. Front Neurol2020; 11: 595042.
61.
DucrosADenierCJoutelA, et al.The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med2001; 345: 17–24.
62.
De FuscoMMarconiRSilvestriL, et al.Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet2003; 33: 192–196.
63.
DichgansMFreilingerTEcksteinG, et al.Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet2005; 366: 371–377.
64.
Paz-TamayoAPerez-CarpenaPLopez-EscamezJA. Systematic review of prevalence studies and familial aggregation in vestibular migraine. Front Genet2020; 11: 954.
WangAZhouGBrodskyJR. Characteristics of benign paroxysmal positional vertigo in young children. Laryngoscope2023; 133: 694–699.
68.
von BrevernMRadtkeALeziusF, et al.Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry2007; 78: 710–715.
69.
PanRQiXWangF, et al.Correlations of calcium voltage-gated channel subunit Alpha1 A (CACNA1A) gene polymorphisms with benign paroxysmal positional vertigo. Med Sci Monit2019; 25: 946–951.
70.
DengMLiuCJiangW, et al.A novel genetic variant associated with benign paroxysmal positional vertigo within the LOXL1. Mol Genet Genomic Med2020; 8: e1469.
71.
XuYZhangYLopezIA, et al.Identification of a genetic variant underlying familial cases of recurrent benign paroxysmal positional vertigo. PLoS One2021; 16: e0251386.
72.
AchardSCampionMParodiM, et al.Recurrent benign paroxysmal positional vertigo in DFNB16 patients with biallelic STRC gene deletions. Otol Neurotol2023; 44: e241–e245.
73.
YangSNSchlieskiTSelminsB, et al.Stereoscopic viewing and reported perceived immersion and symptoms. Optom Vis Sci2012; 89: 1068–1080.
74.
MurrayJB. Psychophysiological aspects of motion sickness. Percept Mot Skills1997; 85: 1163–1167.
75.
SternRMHuSUijtdehaageSH, et al.Asian hypersusceptibility to motion sickness. Hum Hered1996; 46: 7–14.
76.
LentzJMCollinsWE. Motion sickness susceptibility and related behavioral characteristics in men and women. Aviat Space Environ Med1977; 48: 316–322.
77.
TurnerMGriffinMJ. Motion sickness in public road transport: passenger behavior and susceptibility. Ergonomics1999; 42: 444–461.
78.
LorinczDDruryHRSmithDW, et al.Aged mice are less susceptible to motion sickness and show decreased efferent vestibular activity compared to young adults. Brain Behav2023; 13: e3064.
79.
HromatkaBSTungJYKieferAK, et al.Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis. Hum Mol Genet2015; 24: 2700–2708.
80.
ZhangXSunY. The predictive role of ADRA2A rs1800544 and HTR3B rs3758987 polymorphisms in motion sickness susceptibility. Int J Environ Res Publ Health2021; 18: 13163.
81.
HoriiAKoikeKUnoA, et al.Vestibular modulation of plasma vasopressin levels in rats. Brain Res2001; 914: 179–184.
82.
KimMSCheyWDOwyangC, et al.Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. Am J Physiol1997; 272: G853–G862.
83.
XuLHTangGRYangJJ, et al.AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat. Mol Brain2015; 8: 86.
84.
XuLHYangYLiuHX, et al.Inner ear arginine vasopressin-vasopressin receptor 2-Aquaporin 2 signaling pathway is involved in the induction of motion sickness. J Pharmacol Exp Therapeut2020; 373: 248–260.
85.
SatoGUnoAHoriiA, et al.Effects of hypergravity on histamine H1 receptor mRNA expression in hypothalamus and brainstem of rats: implications for development of motion sickness. Acta Otolaryngol2009; 129: 45–51.
86.
TakedaNMoritaMKuboT, et al.Histaminergic mechanism of motion sickness. Neurochemical and neuropharmacological studies in rats. Acta Otolaryngol1986; 101: 416–421.
87.
UnoATakedaNHoriiA, et al.Histamine release from the hypothalamus induced by gravity change in rats and space motion sickness. Physiol Behav1997; 61: 883–887.
88.
ChenMMXuLHChangL, et al.Reduction of motion sickness through targeting Histamine N-Methyltransferase in the dorsal vagal complex of the brain. J Pharmacol Exp Therapeut2018; 364: 367–376.
89.
HurleBIgnatovaEMassironiSM, et al.Non-syndromic vestibular disorder with otoconial agenesis in tilted/mergulhador mice caused by mutations in otopetrin 1. Hum Mol Genet2003; 12: 777–789.
90.
PaffenholzRBergstromRAPasuttoF, et al.Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev2004; 18: 486–491.
91.
NakanoYLongo-GuessCMBergstromDE, et al.Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice. J Clin Investig2008; 118: 1176–1185.
92.
LiXZhangDXuL, et al.Sperm-associated antigen 6 (Spag6) mutation leads to vestibular dysfunction in mice. J Pharmacol Sci2021; 147: 325–330.
93.
TodtIHenniesHCBastaD, et al.Vestibular dysfunction of patients with mutations of connexin 26. Neuroreport2005; 16: 1179–1181.
94.
BalohRWJacobsonKFifeT. Familial vestibulopathy: a new dominantly inherited syndrome. Neurology1994; 44: 20–25.
95.
JenJCWangHLeeH, et al.Suggestive linkage to chromosome 6q in families with bilateral vestibulopathy. Neurology2004; 63: 2376–2379.
96.
LeeHJenJCWangH, et al.A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet2006; 15: 251–258.
97.
NoonanKYRussoJShenJ, et al.CDH23 related hearing loss: a new genetic risk factor for semicircular canal dehiscence?Otol Neurotol2016; 37: 1583–1588.
98.
KirstenEBSchoenerEP. Action of anticholinergic and related agents on single vestibular neurones. Neuropharmacology1973; 12: 1167–1177.
99.
TakedaNMoritaMHasegawaS, et al.Neurochemical mechanisms of motion sickness. Am J Otolaryngol1989; 10: 351–359.
100.
HainTCYacovinoD. Pharmacologic treatment of persons with dizziness. Neurol Clin2005; 23: 831–853.
101.
McClureJALycettPBaskervilleJC. Diazepam as an anti-motion sickness drug. J Otolaryngol1982; 11: 253–259.
102.
ChenSPHsuCLChenTH, et al.A genome-wide association study identifies novel loci of vertigo in an Asian population-based cohort. Commun Biol2024; 7: 1034.
103.
SkuladottirATBjornsdottirGNawazMS, et al.A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigo. Commun Biol2021; 4(2021): 1148.
104.
Escalera-BalseraARobles-BolivarPParra-PerezAM, et al.A rare haplotype of the GJD3 gene segregating in familial Meniere's disease interferes with connexin assembly. Genome Med2025; 17: 4.
105.
BakerKBroughDEStaeckerH. Repair of the vestibular system via adenovector delivery of Atoh1: a potential treatment for balance disorders. Adv Otorhinolaryngol2009; 66: 52–63.
106.
SchleckerCPraetoriusMBroughDE, et al.Selective atonal gene delivery improves balance function in a mouse model of vestibular disease. Gene Ther2011; 18: 884–890.
107.
IsgrigKShteamerJWBelyantsevaIA, et al.Gene therapy restores balance and auditory functions in a mouse model of Usher syndrome. Mol Ther2017; 25: 780–791.
108.
PanBAskewCGalvinA, et al.Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c. Nat Biotechnol2017; 35: 264–272.
